Comparison between tumor and serum HLA class I expression in patients with breast cancer
✍ Scribed by Klein, T.; Warchaizer, S.; Levin, I.; Nyska, A.; Narinsky, R.; Kfir, B.; Livni, E.; Klein, B.
- Book ID
- 122011580
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 160 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0198-8859
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Loss of surface expression of class I major histocompatibility antigens is commonly observed in malignant tumors and has been considered one of the mechanisms for escape from cytotoxic T cells. However, natural killer cells kill cells lacking HLA class I antigens. In the present study, we characteri
Immune recognition of human cancers except melanoma is not well understood at either the cellular or the molecular level. We demonstrate in this study the existence of HLA class-I-restricted and tumor-specific CTL in IL-2-activated TIL (tumor-infiltrating lymphocytes) of all 4 gastric cancer patient